Chemoprophylaxis with hydroxychloroquine for covid-19 infectious disease (prolific) to prevent covid-19 infection in frontline healthcare workers: a structured summary of a study protocol for a randomised controlled trial

HIGHLIGHTS

  • who: Carmel M. McEniery from the Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK have published the article: ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial, in the Journal: (JOURNAL)

SUMMARY

    Supplementary information Supplementary information accompanies this paper at https://doi.org/10. The authors declare that they have no competing interests. File 1. File 2. @@

ACRONYMS

LAY DEFINITIONS

  • Hydroxychloroquine: A chemotherapeutic . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?